Suppr超能文献

豚鼠黏膜下神经元中通过α2肾上腺素能受体进行突触前抑制的潜在机制。

Mechanisms underlying presynaptic inhibition through alpha 2-adrenoceptors in guinea-pig submucosal neurones.

作者信息

Shen K Z, Surprenant A

机构信息

Vollum Institute, Oregon Health Sciences University, Portland 97201.

出版信息

J Physiol. 1990 Dec;431:609-28. doi: 10.1113/jphysiol.1990.sp018350.

Abstract
  1. Intracellular recordings were made from submucosal neurones of the guinea-pig ileum. The actions of noradrenaline, somatostatin and [Met5]enkephalin on nicotinic synaptic potentials (EPSPs) were studied. 2. In one series of experiments, agonists were applied by superfusion; noradrenaline (0.1-20 microM) decreased EPSP amplitude by 95-100% in all neurones. Similar application of somatostatin (1-100 nM) inhibited EPSPs in about half the neurones by a maximum of 40%. [Met5]enkephalin (0.1-10 microM) did not alter EPSPs. Idazoxan and yohimbine competitively antagonized the action of noradrenaline with dissociation equilibrium constants of 20 and 30 nM respectively. 3. In another series of experiments, noradrenaline and somatostatin were applied locally from a pipette so that they reached presynaptic terminals but not the cell bodies or axons of the presynaptic cell: noradrenaline inhibited EPSPs by 90% in all neurones but somatostatin had no effect. When applied locally to the cell bodies giving rise to the presynaptic fibres, both agonists inhibited EPSPs in half the neurones by 40%. 4. When noradrenaline was applied locally to presynaptic terminals, the latency to onset of noradrenaline to inhibit EPSPs was 45-160 ms; cadmium applied similarly depressed EPSPs in 5-50 ms. 5. Pertussis toxin pre-treatment only partially blocked presynaptic inhibition caused by noradrenaline but abolished the reduction of EPSP amplitude by somatostatin. 6. It is concluded that noradrenaline and somatostatin reduce the amplitude of the fast EPSP because they hyperpolarize cell bodies and prevent action potential initiation. Noradrenaline, but not somatostatin, has an additional action to inhibit acetylcholine release by acting at nerve terminal receptors. 7. The presynaptic inhibitory action of noradrenaline results from activation of alpha 2-adrenoceptors at nerve terminals but the mechanism(s) by which these presynaptic receptors act cannot be explained adequately by either activation of a potassium conductance and/or inhibition of a calcium conductance.
摘要
  1. 对豚鼠回肠黏膜下神经元进行细胞内记录。研究了去甲肾上腺素、生长抑素和[Met5]脑啡肽对烟碱型突触电位(兴奋性突触后电位,EPSP)的作用。2. 在一系列实验中,通过灌流施加激动剂;去甲肾上腺素(0.1 - 20微摩尔)使所有神经元的EPSP幅度降低95 - 100%。类似地施加生长抑素(1 - 100纳摩尔)使约一半神经元的EPSP受到抑制,最大抑制率为40%。[Met5]脑啡肽(0.1 - 10微摩尔)未改变EPSP。育亨宾和咪唑克生分别以20和30纳摩尔的解离平衡常数竞争性拮抗去甲肾上腺素的作用。3. 在另一系列实验中,从移液管局部施加去甲肾上腺素和生长抑素,使其到达突触前终末,但不接触突触前细胞的胞体或轴突:去甲肾上腺素使所有神经元的EPSP受到90%的抑制,但生长抑素无作用。当局部施加于产生突触前纤维的胞体时,两种激动剂使约一半神经元的EPSP受到40%的抑制。4. 当局部将去甲肾上腺素施加于突触前终末时,去甲肾上腺素开始抑制EPSP的潜伏期为45 - 160毫秒;类似地施加镉在5 - 50毫秒内使EPSP降低。5. 百日咳毒素预处理仅部分阻断去甲肾上腺素引起的突触前抑制,但消除了生长抑素导致的EPSP幅度降低。6. 得出结论,去甲肾上腺素和生长抑素降低快速EPSP的幅度是因为它们使胞体超极化并阻止动作电位的产生。去甲肾上腺素而非生长抑素通过作用于神经终末受体具有额外抑制乙酰胆碱释放的作用。7. 去甲肾上腺素的突触前抑制作用源于神经终末α2 - 肾上腺素能受体的激活,但这些突触前受体发挥作用的机制不能通过激活钾电导和/或抑制钙电导来充分解释。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7039/1181794/fb7a6599a931/jphysiol00454-0604-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验